DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Jagsonpal Pharmaceuticals Limited — Outcome of Board Meeting

NSE 2 hrs ago·28 Oct 2026, 12:43 pm

Jagsonpal Pharmaceuticals

Jagsonpal Pharmaceuticals Limited has announced its financial results for the quarter ending September 30, 2026. The company has formally submitted these updates to the stock exchanges, marking a standard corporate disclosure regarding its performance during this period.

For investors, this filing is a key data point to gauge the company's operational health and financial trajectory. It provides the latest figures needed to assess the firm's current standing and helps in tracking its progress against market expectations.

Investors should closely review the detailed financial statements released alongside this announcement. Monitoring the company's performance trends over the coming quarters will be essential to understand the sustainability of its business operations.